CL2018003107A1 - Procedimiento para la preparación de derivados de 1-fenilo-1,2,4-triazol sustituidos por 5-hidroxialquilo - Google Patents

Procedimiento para la preparación de derivados de 1-fenilo-1,2,4-triazol sustituidos por 5-hidroxialquilo

Info

Publication number
CL2018003107A1
CL2018003107A1 CL2018003107A CL2018003107A CL2018003107A1 CL 2018003107 A1 CL2018003107 A1 CL 2018003107A1 CL 2018003107 A CL2018003107 A CL 2018003107A CL 2018003107 A CL2018003107 A CL 2018003107A CL 2018003107 A1 CL2018003107 A1 CL 2018003107A1
Authority
CL
Chile
Prior art keywords
preparation
phenyl
triazol
hydroxyalkyl
triazole derivatives
Prior art date
Application number
CL2018003107A
Other languages
English (en)
Spanish (es)
Inventor
Kersten Matthias Gericke
Frank Süssmeier
Marie-Pierre Collin-Kröpelin
Thomas Neubauer
Chantal Fürstner
Heiko Schirmer
Philipp Rubenbauer
Hans-Christian Militzer
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of CL2018003107A1 publication Critical patent/CL2018003107A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
CL2018003107A 2016-05-03 2018-10-31 Procedimiento para la preparación de derivados de 1-fenilo-1,2,4-triazol sustituidos por 5-hidroxialquilo CL2018003107A1 (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP16168166 2016-05-03
EP16168169 2016-05-03
EP16168163 2016-05-03
EP16168172 2016-05-03
EP16168165 2016-05-03
EP17160086 2017-03-09

Publications (1)

Publication Number Publication Date
CL2018003107A1 true CL2018003107A1 (es) 2019-02-22

Family

ID=58633014

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2018003107A CL2018003107A1 (es) 2016-05-03 2018-10-31 Procedimiento para la preparación de derivados de 1-fenilo-1,2,4-triazol sustituidos por 5-hidroxialquilo

Country Status (19)

Country Link
US (2) US10703742B2 (2)
EP (1) EP3452467A1 (2)
JP (2) JP6921863B2 (2)
KR (1) KR20190003536A (2)
CN (2) CN113105403A (2)
AU (2) AU2017259872B2 (2)
BR (1) BR112018072528A2 (2)
CA (1) CA3022789A1 (2)
CL (1) CL2018003107A1 (2)
CO (1) CO2018011948A2 (2)
IL (1) IL262534B (2)
JO (1) JOP20170103A1 (2)
MX (2) MX379555B (2)
PE (1) PE20190202A1 (2)
RU (1) RU2742885C2 (2)
SG (1) SG11201809672YA (2)
TW (1) TWI755393B (2)
UY (1) UY37222A (2)
WO (1) WO2017191104A1 (2)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9988367B2 (en) * 2016-05-03 2018-06-05 Bayer Pharma Aktiengesellschaft Amide-substituted pyridinyltriazole derivatives and uses thereof
JOP20170103A1 (ar) * 2016-05-03 2017-11-03 Bayer Pharma AG عملية لتحضير مشتقات 1-فنيل-1، 2، 4-تريازول مستبدلة بـ 5-هيدروكسي ألكيل
WO2017191115A1 (en) * 2016-05-03 2017-11-09 Bayer Pharma Aktiengesellschaft Oxoalkyl-substituted phenyltriazole derivatives and uses thereof
WO2021259852A1 (en) 2020-06-25 2021-12-30 Bayer Aktiengesellschaft Process for preparing 5-(alkoxycarbonyl)-and 5-(carboxamide)-1-aryl-1,2,4-triazole derivatives
CN118894815A (zh) * 2024-07-12 2024-11-05 西北师范大学 一种含三氟甲基的1,2,4-三氮唑啉类衍生物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2038262B1 (en) * 2006-05-25 2014-11-12 Synta Pharmaceuticals Corp. Triazole compounds that modulate hsp90 activity
JP2012503005A (ja) * 2008-09-19 2012-02-02 インスティテュート フォア ワンワールド ヘルス イミダゾール誘導体およびトリアゾール誘導体を含む、化合物、組成物ならびに方法。
DE102010001064A1 (de) * 2009-03-18 2010-09-23 Bayer Schering Pharma Aktiengesellschaft Substituierte 2-Acetamido-5-Aryl-1,2,4-triazolone und deren Verwendung
UA109650C2 (xx) * 2010-02-27 2015-09-25 Біс-арилзв'язані арилтриазолони та їх застосування
PL2847183T3 (pl) * 2012-05-08 2017-11-30 Bayer Pharma Aktiengesellschaft Sposób wytwarzania związków triazolowych
SI3215498T1 (sl) * 2014-11-03 2018-11-30 Bayer Pharma Aktiengesellschaft Hidroksialkil-substituirani derivati feniltriazola in njihove uporabe
US9988367B2 (en) * 2016-05-03 2018-06-05 Bayer Pharma Aktiengesellschaft Amide-substituted pyridinyltriazole derivatives and uses thereof
JOP20170103A1 (ar) * 2016-05-03 2017-11-03 Bayer Pharma AG عملية لتحضير مشتقات 1-فنيل-1، 2، 4-تريازول مستبدلة بـ 5-هيدروكسي ألكيل
WO2017191115A1 (en) * 2016-05-03 2017-11-09 Bayer Pharma Aktiengesellschaft Oxoalkyl-substituted phenyltriazole derivatives and uses thereof

Also Published As

Publication number Publication date
MX379555B (es) 2025-03-11
US20200299271A1 (en) 2020-09-24
MX391356B (es) 2025-03-19
AU2017259872B2 (en) 2021-06-24
CN109071500A (zh) 2018-12-21
MX2018013336A (es) 2019-05-09
RU2742885C2 (ru) 2021-02-11
WO2017191104A1 (de) 2017-11-09
AU2021236502A1 (en) 2021-10-21
CA3022789A1 (en) 2017-11-09
JP2021143193A (ja) 2021-09-24
JP6921863B2 (ja) 2021-08-18
MX2020010365A (es) 2022-04-06
TWI755393B (zh) 2022-02-21
JOP20170103A1 (ar) 2017-11-03
CN109071500B (zh) 2021-05-18
KR20190003536A (ko) 2019-01-09
RU2018142264A3 (2) 2020-08-19
IL262534B (en) 2021-04-29
BR112018072528A2 (pt) 2019-03-26
JP2019514948A (ja) 2019-06-06
EP3452467A1 (de) 2019-03-13
RU2018142264A (ru) 2020-06-03
AU2017259872A1 (en) 2018-11-22
CN113105403A (zh) 2021-07-13
UY37222A (es) 2017-11-30
IL262534A (en) 2018-12-31
US10703742B2 (en) 2020-07-07
PE20190202A1 (es) 2019-02-05
US20190144431A1 (en) 2019-05-16
CO2018011948A2 (es) 2018-11-22
SG11201809672YA (en) 2018-11-29
TW201815782A (zh) 2018-05-01

Similar Documents

Publication Publication Date Title
CL2018003107A1 (es) Procedimiento para la preparación de derivados de 1-fenilo-1,2,4-triazol sustituidos por 5-hidroxialquilo
PE20170945A1 (es) Derivados de feniltriazol sustituido con hidroxialquilo y sus usos
EA201390275A1 (ru) Кристаллический (r)-(e)-2-(4-(2-(5-(1-(3,5-дихлорпиридин-4-ил)этокси)-1h-индазол-3-ил)винил)-1h-пиразол-1-ил)этанол
CL2014000384A1 (es) Compuestos fungicidas de 1-(2-(2-halo-4-(4-halogen-fenoxi)-fenil)-2-alcoxi-2-alquinil/alquenil-etil)-1h-(1,2,4) triazol sustituidos; proceso para preparar dichos compuestos; composiciones agroquímicas.
EA202091506A1 (ru) Триазол n-связанные карбамоил циклогексильные кислоты в качестве антагонистов lpa
MX2020005818A (es) Triazol azoles de acido ciclohexilo como antagonistas de acido lisofosfatidico (lpa).
AR078411A1 (es) Compuesto de vinil imidazolilo y composicion farmaceutica que lo comprende
CL2014000201A1 (es) Compuestos fungicidas de 1-(2-(2-halo-4-(4-halogen-fenoxi)-fenil)-2-aluiniloxi-etil)-1h-(1,2,4)triazol sustituidos; procesos para preparar dichos compuestos; uso de dichos compuestos para combatir hongos fitopatógenos.
CO6900161A2 (es) Compuestos fungicidas de 1-{2-[2-halo-4-(4-halogen-fenoxi)-fenil]-2-alcoxi-2-ciclil-etil}-1h-[1,2,4]triazol sustituidos
CO6900157A2 (es) Compuestos fungicidas de 1-{2-[2-halo-4-(4-halogen-fenoxi)-fenil]-2-etoxi-etil}-1h-[1,2,4]triazol sustituidos
CO6900159A2 (es) Compuestos fungicidas de 1-{2-[2-halo-4-(4-halogen-fenoxi)-fenil]-2-alcoxi-3-metil-butil}-1h-[1,2,4]triazol sustituidos
AR104695A1 (es) Compuestos fungicidas
NZ627113A (en) Substituted pyrimidine compounds and their use as syk inhibitors
CL2016003175A1 (es) Compuestos de [1, 2, 4 ] triazol e imidazol sustituidos
CL2016002886A1 (es) Compuestos de [1,2,4]triazol e imidazol sustituidos como fungicidas.
CL2014003003A1 (es) Proceso para la preparacion de 1-[6-(morfolin—4-il)pirimidin-4-il]-4-(1h-1,2,3-triazol-1-il)-1h-pirazol-5-ol (i – forma enol) o de 2-[6-(morfolin-4-il)pirimidin-4-il]-4-(1h-1,2,3-triazol-1-il)-1,2-dihidro-3h-pirazol-3-ona (i – forma ceto); y compuesto intermediario (2e/z)-3-(dimetilamino)-2-(1h-1,2,3-triazol-1-il) acrilato de metilo.
MX363432B (es) Derivados 1-(piperazin-1-il)-2-([1,2,4]triazol-1-il)-etanona.
MY188699A (en) Processes for preparing (cyclopentyl[d]pyrimidin-4-yl)piperazine compounds
EP3233824A4 (en) (s)-n-(3-(6-isopropoxypyridin-3-yl)-1h-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2h)-yl)-2-oxoethyl)-3- (methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations
EP3810597C0 (en) 1,2,4-TRIAZOLE DERIVATIVES AS TANKYRASE INHIBITORS
NZ735783A (en) Antifungal 4-(4-(4-(((3r,5r)-5-((1 h -1,2,4-triazol-1 -yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)- 3-methylphenyl)piperazin-1 -yl )-n -(2-h yd roxycyc lo h exyl) b e nzam i d e, or a pharmaceutically acceptable salt thereof.
EP3233079A4 (en) (s)-n-(3-(6-isopropoxypyridin-3-yl)-1h-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2h)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations
PL3983402T4 (pl) Pochodne 1-((s)-1-(3-chloro-5-fluoro-2-((4-(1h-pirazol-1-ilo)-2-metylochinolin-8-yloksy)metylo)fenylo)etylo)imidazolidyno-2,4-dionu i związki pokrewne jako antagoniści receptora bradykininy (bk) b2 do leczenia chorób skóry
UA98919U (ru) 4-этил-3-(феноксиметил)-5-((2-((5-феноксиметил)-4-фенил-4н-1,2,4-триазол-3-ил)тио)этил)тио)-4н-1,2,4-триазол, проявляющая диуретическую активность
EP3166404A4 (en) Improved process for preparation of 4-(1-(4-(perfluoroethoxy)phenyl)-1h-1,2,4-triazol-3-yl)benzoyl azide